The analyses of diagnostic accuracy of markers CK-19, Gal-3 and HBME-1, and their associations, in the differentiation of well-differentiated carcinoma and benign thyroid lesions, were evaluated separately by the immunohistochemistry and immunocytochemistry techniques, as described below. The gene discussed is KRT19; the disease is carcinoma.